JONATHAN CORREN: Open Payments
NPI 1447360086 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74,318 in 131 payments from 26 companies in 2025. Trend: 2023 $97,826 · 2024 $58,518 · 2025 $74,318
Speaker / faculty: $50,696Consulting: $18,425Food & beverage: $2,617Travel & lodging: $2,580
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 33 | $35,852 |
| Regeneron Healthcare Solutions, Inc. | 11 | $14,699 |
| GENZYME CORPORATION | 17 | $12,528 |
| GlaxoSmithKline, LLC. | 9 | $3,879 |
| Amgen Inc. | 5 | $3,278 |
| Eli Lilly and Company | 4 | $2,275 |
| ABBVIE INC. | 1 | $550 |
| CSL Behring | 11 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $158 |
| PFIZER INC. | 8 | $158 |
Products named: TEZSPIRE, DUPIXENT, Hizentra, CIBINQO, NUCALA, Rhapsido, ORLADEYO, Xolair.
Industry payments across CA — which companies pay providers there.
